U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07655154) titled 'Evaluation of biomArkers for Quick SEpsis Diagnosis - ErASED Study' on May 14.
Brief Summary: Since the "Sepsis-3" consensus statement in 2016, sepsis has been defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. Recognition of sepsis is mostly based on clinical criteria. To aid diagnosis, a wide range of biomarkers has been identified, however, with few exceptions such as procalcitonin, none is part of the routine assessment of a septic patient. Proadrenomedullin, serum calprotectin and a score of combined values of IL-6 + IL-8 + IL-10 + MCP-1 have been proposed as biomarkers to aid d...